Smart Valved Holding Chamber with Flow Sensor Feedback
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Patients using metered dose inhalers (MDIs) and valved holding chambers (VHCs) often exhibit poor adherence to medication regimens and improper inhalation techniques, leading to suboptimal treatment outcomes and increased healthcare costs, as existing systems lack the ability to monitor and provide feedback on medication usage and inhalation technique.
Innovation Solution
A smart VHC system that identifies the MDI, monitors inhalation flow rates, provides real-time feedback on technique, and notifies users when the correct time to actuate the MDI, ensuring proper dose delivery, with features like LEDs, displays, audio, and haptic feedback to improve adherence and technique.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a VHC system is equipped with monitoring and feedback capabilities, then patient adherence and inhalation technique are improved, but device complexity increases
Solution Approach 1:
The system incorporates flow sensors that detect inhalation flow rates and provide real-time feedback to the user through visual indicators (LEDs) and audible signals. The system monitors whether the user is breathing too fast, holds their breath adequately, and coordinates MDI actuation with inhalation timing. This feedback mechanism directly improves patient adherence and inhalation technique by guiding users on proper usage.
Solution Approach 2:
The patent replaces complex mechanical monitoring systems with electronic sensing and digital processing. Flow sensors use electrical circuits to detect airflow patterns, and a microprocessor analyzes the data to determine inhalation technique. This substitution of mechanical systems with electronic and software-based solutions reduces overall device complexity while maintaining monitoring capabilities.
2Reliability
If a VHC system monitors and communicates medication use, then medication compliance is improved, but manufacturing cost increases
Solution Approach 1:
The system automatically monitors and records medication usage without requiring external intervention. The flow sensors continuously detect inhalation events, the microprocessor automatically logs compliance data, and the system provides real-time feedback to confirm proper usage. This self-monitoring capability improves medication compliance while avoiding the need for complex external monitoring infrastructure that would increase manufacturing costs.
Solution Approach 2:
The system uses inexpensive flow sensors that detect airflow parameters (flow rate, duration, timing) to infer medication compliance. By monitoring physical parameters like flow rate thresholds and inhalation timing rather than requiring complex chemical or biological markers, the system achieves reliable compliance tracking at lower manufacturing cost.
3Reliability
If the system provides real-time feedback on inhalation technique, then treatment effectiveness is improved, but energy consumption increases
Solution Approach 1:
The feedback system operates periodically during the inhalation process rather than continuously. Flow sensors activate during inhalation events to provide real-time feedback, then enter low-power states between inhalations. The microprocessor processes data and controls feedback indicators in periodic cycles synchronized with the breathing pattern, reducing overall energy consumption while maintaining treatment effectiveness during active inhalation.
Solution Approach 2:
The system replaces energy-intensive mechanical feedback mechanisms with low-power electronic indicators. Visual feedback uses LED lights that consume minimal energy, and audible feedback uses efficient piezoelectric buzzers rather than mechanical speakers. The electronic sensing and digital processing require far less energy than mechanical monitoring and feedback systems would consume.
Data Source
AI summary
A medication delivery system having a holding chamber capable of delivering dosages of medicament from a metered dose inhaler. The holding chamber includes an actuator detector, flow detector and display. In another embodiment, a medication delivery system includes a holding chamber having an input and an output end, a metered dose inhaler operably coupled to the input end of the holding chamber, and a metered dose inhaler identifier associated with the holding chamber and operable to identify the metered dose inhaler coupled to the holding chamber.